Trials
Search / Trial NCT05651139

Vibration Device Effect on Post-Injection Pain in The Upper Extremity

Launched by HATAN MORTADA · Dec 6, 2022

Apply for Trial

Trial Information

Current as of January 14, 2025

Unknown status

Keywords

Vibration Simulation Vibration Therapy Post Injection Pain Upper Extremity Injection Pain

ClinConnect Summary

Study design:

randomized controlled trial

Study duration:

12 months, beginning in November 2022 and ending in May 2023.

Study settings:

Data will be collected from patients coming to the plastic surgery department.

Study population: adult patients scheduled to receive local anesthesia or corticosteroid injections in their upper extremities.

Eligibility criteria: Adult patients with (ASA) physical status class 1 who are scheduled to receive local anesthesia or corticosteroid injections

Sample size:

60 adult patients who are attending plastic surgery clinic for upper extremity inject...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • At least 18 years of age
  • • American Society of Anesthesiologists (ASA) physical status class I
  • • Pain free
  • • Adult patients scheduled to receive local anesthesia or corticosteroid injections in their upper extremities
  • Exclusion Criteria:
  • • Those on analgesic medications
  • • Alcoholics, drug abusers
  • • Pregnant patients
  • • Menstruating women
  • • Patients with reported allergies
  • • Patients with acute infections

About Hatan Mortada

Hatan Mortada is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapeutic solutions, Hatan Mortada collaborates with leading research institutions and healthcare professionals to ensure rigorous study design and ethical conduct in clinical trials. The organization prioritizes patient safety and data integrity, leveraging cutting-edge methodologies to facilitate the discovery of effective treatments across various therapeutic areas. Through its strategic partnerships and commitment to excellence, Hatan Mortada aims to contribute significantly to the enhancement of global health outcomes.

Locations

Riyadh, Central Region, Saudi Arabia

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials